125 related articles for article (PubMed ID: 32003204)
1. Incidental prostate cancer after transurethral resection of the prostate: analysis of incidence and risk factors in 458 patients.
Porcaro AB; Tafuri A; Inverardi D; Amigoni N; Sebben M; Pirozzi M; Processali T; Rizzetto R; Shakir A; Cerrato C; Tiso L; Panunzio A; DE Michele M; Brunelli M; Siracusano S; Artibani W
Minerva Urol Nephrol; 2021 Aug; 73(4):471-480. PubMed ID: 32003204
[TBL] [Abstract][Full Text] [Related]
2. "Finding the needle in a haystack": oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP).
Herlemann A; Wegner K; Roosen A; Buchner A; Weinhold P; Bachmann A; Stief CG; Gratzke C; Magistro G
World J Urol; 2017 Nov; 35(11):1777-1782. PubMed ID: 28516315
[TBL] [Abstract][Full Text] [Related]
3. The Influence of Endogenous Testosterone on Incidental Prostate Cancer after Transurethral Prostate Resection.
Porcaro AB; Siracusano S; Amigoni N; Tafuri A; Rizzetto R; Shakir A; Tiso L; Cerrato C; De Michele M; Bianchi A; Gallina S; Brunelli M; Migliorini F; Artibani W; Antonelli A
Urol Int; 2021; 105(9-10):826-834. PubMed ID: 33965959
[TBL] [Abstract][Full Text] [Related]
4. Is the systematic histological analysis of benign prostatic hyperplasia surgical specimen always necessary?
Coman R; Anract J; Pinar U; Sibony M; Peyromaure M; Delongchamps B
Int Urol Nephrol; 2022 Jul; 54(7):1485-1489. PubMed ID: 35536389
[TBL] [Abstract][Full Text] [Related]
5. HoLEP provides a higher prostate cancer detection rate compared to bipolar TURP: a matched-pair analysis.
Rosenhammer B; Lausenmeyer EM; Mayr R; Burger M; Eichelberg C
World J Urol; 2018 Dec; 36(12):2035-2041. PubMed ID: 29858700
[TBL] [Abstract][Full Text] [Related]
6. Serum early prostate cancer antigen (EPCA) as a significant predictor of incidental prostate cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Zeng G; Zhong W
Prostate; 2010 Dec; 70(16):1788-98. PubMed ID: 20583137
[TBL] [Abstract][Full Text] [Related]
7. PSCA mRNA expression in preoperatively negative prostate biopsies predicts incidental prostate cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Ma W; Zeng G; Qi D
J Surg Oncol; 2011 Nov; 104(6):672-8. PubMed ID: 21674503
[TBL] [Abstract][Full Text] [Related]
8. Incidence, predictive factors and oncological outcomes of incidental prostate cancer after endoscopic enucleation of the prostate: a systematic review and meta-analysis.
Cheng BK; Castellani D; Chan IS; Baker A; Gauhar V; Wroclawski ML; Santamaria HT; Tanidir Y; Enikeev D; Chan VW; Ng CF; Herrmann T; Teoh JY
World J Urol; 2022 Jan; 40(1):87-101. PubMed ID: 34142230
[TBL] [Abstract][Full Text] [Related]
9. Factors Associated with Urethral and Bladder Neck Stricture After Transurethral Resection of the Prostate.
Garza-Montúfar ME; Cobos-Aguilar H; Treviño-Baez JD; Pérez-Cortéz P
J Endourol; 2021 Sep; 35(9):1400-1404. PubMed ID: 33849284
[No Abstract] [Full Text] [Related]
10. "In-bore" MRI prostate biopsy is a safe preoperative clinical tool to exclude significant prostate cancer in symptomatic patients with benign prostatic obstruction before transurethral laser enucleation.
Porreca A; D'Agostino D; Vigo M; Corsi P; Romagnoli D; Del Rosso A; Schiavina R; Brunocilla E; Artibani W; Giampaoli M
Arch Ital Urol Androl; 2020 Jan; 91(4):224-229. PubMed ID: 31937084
[TBL] [Abstract][Full Text] [Related]
11. Is there a PSA cut-off value indicating incidental prostate cancer in patients undergoing surgery for benign prostatic hyperplasia?
Tonyali S; Ceylan C; Aglamis E; Dogan S; Tastemur S; Karaaslan M
Arch Ital Urol Androl; 2021 Mar; 93(1):31-34. PubMed ID: 33754606
[TBL] [Abstract][Full Text] [Related]
12. Does mechanical morcellation of large glands compromise incidental prostate cancer detection on specimen analysis? A pathological comparison with open simple prostatectomy.
Misraï V; Kerever S; Pasquie M; Bordier B; Guillotreau J; Palasse J; Guillotreau V; Rijo E; Vincendeau S; Huet R; Mathieu R; Peyronnet B; Rioux-Leclercq N; Compérat EM
World J Urol; 2019 Jul; 37(7):1315-1320. PubMed ID: 30350017
[TBL] [Abstract][Full Text] [Related]
13. Incidentally Detected Adenocarcinoma Prostate in Transurethral Resection of Prostate Specimens: a Hospital Based Study from India.
Varghese J; Kuruvilla PM; Mehta N; Rathore RS; Babu M; Bansal D; Pillai B; Sam MP; Krishnamorthy H
Asian Pac J Cancer Prev; 2016; 17(4):2255-8. PubMed ID: 27221926
[TBL] [Abstract][Full Text] [Related]
14. Incidence and factors predicting the detection of prostate cancer after transurethral resection of the prostate for clinically benign disease.
Bright EA; Manuel C; Goddard JC; Khan MA
Urol Int; 2009; 83(2):171-4. PubMed ID: 19752612
[TBL] [Abstract][Full Text] [Related]
15. Preoperative clinical factors for diagnosis of incidental prostate cancer in the era of tissue-ablative surgery for benign prostatic hyperplasia: a korean multi-center review.
Yoo C; Oh CY; Kim SJ; Kim SI; Kim YS; Park JY; Seong do H; Song YS; Yang WJ; Chung HC; Cho IR; Cho SY; Cheon SH; Hong S; Cho JS
Korean J Urol; 2012 Jun; 53(6):391-5. PubMed ID: 22741046
[TBL] [Abstract][Full Text] [Related]
16. Urethral strictures after bipolar transurethral resection of prostate may be linked to slow resection rate.
Tan GH; Shah SA; Ali NM; Goh EH; Singam P; Ho CCK; Zainuddin ZM
Investig Clin Urol; 2017 May; 58(3):186-191. PubMed ID: 28480344
[TBL] [Abstract][Full Text] [Related]
17. Analysis of risk factors leading to postoperative urethral stricture and bladder neck contracture following transurethral resection of prostate.
Tao H; Jiang YY; Jun Q; Ding X; Jian DL; Jie D; Ping ZY
Int Braz J Urol; 2016; 42(2):302-11. PubMed ID: 27256185
[TBL] [Abstract][Full Text] [Related]
18. Incidental Prostate Cancer in Patients Treated for Benign Prostatic Hyperplasia: Analysis from a Contemporary National Dataset.
Bologna E; Licari LC; Franco A; Ditonno F; Manfredi C; De Nunzio C; Antonelli A; De Sio M; Leonardo C; Simone G; Cherullo EE; Autorino R
Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611590
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for incidental prostate cancer-who should not undergo vaporization of the prostate for benign prostate hyperplasia?
Voigt S; Hüttig F; Koch R; Propping S; Propping C; Grimm MO; Wirth M
Prostate; 2011 Sep; 71(12):1325-31. PubMed ID: 21308716
[TBL] [Abstract][Full Text] [Related]
20. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
